Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Eur J Emerg Med ; 7(4): 261-5, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11764133

RESUMO

The aim of this study was to evaluate the influence of a short-stay observation unit (SSOU) on the hospitalization rate, the authors have analysed the activity of a SSOU opened in 1992 in a paediatric emergency department (PED) and the number of children hospitalized between 1987 and 1996. Among 2321 patients admitted to the SSOU in 1996, 644 medical patients have been analysed, showing a young population (55% under 3 years old), living in the town or surroundings (70%) and usually have not been referred by a general practitioner (64%). Twenty per cent were admitted for accurate diagnosis (group A), 49% for treatment and observation of a recognized acute pathology before decision of discharge (group B), and 31% waiting for a bed in a paediatric ward (group C). Sixty-eight per cent of children spent less than 6 hours in the SSOU, and 79% of those from groups A and B were thereafter discharged home. Between 1987 and 1991, the number of children hospitalized increased 5% per year on average. After the opening of the SSOU in 1992, this increase has been stopped although the number of medical referrals to PED was still going up. The SSOU in a PED can provide comprehensive care to young children requiring short-term treatment or observation, and is effective in limiting unappropriate hospitalizations.


Assuntos
Serviço Hospitalar de Emergência/organização & administração , Unidades Hospitalares/organização & administração , Hospitais Pediátricos/organização & administração , Admissão do Paciente/estatística & dados numéricos , Adolescente , Criança , Pré-Escolar , Feminino , França , Humanos , Lactente , Tempo de Internação , Masculino , Observação
2.
Ann Cardiol Angeiol (Paris) ; 63(2): 107-10, 2014 Apr.
Artigo em Francês | MEDLINE | ID: mdl-22260907

RESUMO

AIM: The aim of this case report was to show the importance to research metabolic etiology, especially a carnitine deficiency in dilated cardiomyopathy of children. CASE REPORT: A three years old Togolese child presented muscular hypotonia, dyspnea. Examination showed left galop murmur and systolic murmur 2/6. Chest X-ray showed cardiomegaly (CTI: 0.66), electrocardiogram, a sinusal rythm, left ventricle hypertrophy and T wave abnormalities. Echocardiogram showed a markedly dilated left ventricle with reduced systolic function (EF: 0.43; reference range 0.55-0.80) and moderate mitral regurgitation. The inflammatory signs where negatives. Magnetic resonance imaging don't show signs of ischemic or myocarditis. The levels of free and total plasmatic carnitine decreased: 3µmol/L (N: 18-48µmol/L) and 5µmol/l (N: 29-70µmol/L) respectively. Mutation analysis of the gene SLC22A5 confirms the diagnosis of primary systemic carnitine deficiency. Treatment with oral carnitine was started at 200mg/kg per day. Within three weeks of treatment, we observed the decrease of all symptoms and the left ventricular size and function normalized (EF: 0.62). He has now been on oral carnitine for live. CONCLUSION: Primary carnitine deficiency is a cause of dilated cardiomyopathy in child. It must systematically be suspected when a child presents a primitive cardiomyopathy. The treatment with oral carnitine for live is simple, with excellent prognosis.


Assuntos
Cardiomiopatias/genética , Cardiomiopatia Dilatada/genética , Carnitina/deficiência , Hiperamonemia/genética , Doenças Musculares/genética , Mutação , Proteínas de Transporte de Cátions Orgânicos/genética , Biomarcadores/sangue , Cardiomiopatias/complicações , Cardiomiopatias/diagnóstico , Cardiomiopatias/tratamento farmacológico , Cardiomiopatia Dilatada/diagnóstico , Cardiomiopatia Dilatada/tratamento farmacológico , Cardiomiopatia Dilatada/etiologia , Carnitina/administração & dosagem , Carnitina/genética , Carnitina/uso terapêutico , Pré-Escolar , Dispneia/etiologia , Humanos , Hiperamonemia/complicações , Hiperamonemia/diagnóstico , Hiperamonemia/tratamento farmacológico , Masculino , Doenças Musculares/complicações , Doenças Musculares/diagnóstico , Doenças Musculares/tratamento farmacológico , Prognóstico , Membro 5 da Família 22 de Carreadores de Soluto , Fatores de Tempo , Resultado do Tratamento , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA